QuantumScape Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that QuantumScape Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($435.05M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($477.86M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($445.15M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($411.91M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($45.97M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($1.68B) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($51.28M) | Feb 28, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($472.60M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($525.21M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($479.03M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($420.62M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($215.27M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($81.02M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($55.82M) | Feb 28, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $375.61M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $382.97M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $347.95M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $297.44M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $151.50M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $65.10M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $45.94M | Feb 28, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($242.47M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($274.56M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($240.03M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($218.02M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($127.91M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($61.26M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($41.73M) | Feb 28, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.28M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $62.25M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $84.62M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $158.85M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $127.18M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $24.09M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $9.85M | Feb 28, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.31B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.32B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.50B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.48B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.72B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.07B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $172.38M | May 7, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.18M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $164.55M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $161.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $155.86M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $107.06M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $713.29M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $21.98M | May 7, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.16B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.34B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $1.32B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $1.61B | Feb 26, 2025 |
| FY2023 | Dec 31, 2020 | $351.77M | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $148.69M | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $191.23M | Feb 28, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.79B) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($3.36B) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($2.88B) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($2.44B) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($2.02B) | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | ($1.98B) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($295.86M) | May 7, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $230.52M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $140.87M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $142.52M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $235.39M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $320.70M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $113.22M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $22.82M | Feb 28, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | (6) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 28, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | (6) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 28, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Nov 25, 2020 | 22.98M | Feb 28, 2022 |
| FY2021 | Nov 24, 2020 | 23.00M | Feb 28, 2022 |